Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.11 (overall 0.07) | 0.11 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 69 | 0.91 |
| pathways Reactome | 3 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 3889
Sealed predictions
- FGD4 in dopamine neurons, braak-0.50 (p 0.172) → -0.44 (p 0.234)receipt 3895
Swarm cases
receipt 3895: FGD4 in dopamine neurons, braak
- power
- full sample -0.45 (p 0.062, n 18), 95% CI -0.76 to +0.02. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.51 (p 0.031, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.52 (p 0.026, n 18). not the mix.
- skeptic
- leave-one-out range -0.60 to -0.37, sign flips 0; without severely affected donors -0.45 (p 0.062, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FGD4 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts